Literature DB >> 6113175

Comparative efficacy of lormetazepam (Noctamid) and diazepam (Valium) in 100 out-patients with insomnia.

M S Sastre y Hernández, H D Hentschel, K Fichte.   

Abstract

Lormetazepam (Noctamid) at a dosage of 1 mg was compared with diazepam (Valium) at a dosage of 5 mg in a 7-day double-blind study. The study involved fifty patients in the lormetazepam group and fifty patients in the diazepam group. All the patients were suffering from sleep disorders as a concomitant symptom of general diseases. Lormatazepam was significantly better than diazepam in the: -Reduction of the time taken to fall asleep (p less than 0.05) -Prolongation of the duration of uninterrupted sleep (p less than 0.05) -Reduction of the frequency of awakening (p less than 0.05). Lormetazepam displayed no hang-over effects or other side-effects and, in this respect too, was significantly superior to diazepam (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113175     DOI: 10.1177/030006058100900309

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  4 in total

1.  Photopotentiation of the GABAA receptor with caged diazepam.

Authors:  Lorenzo Sansalone; Joshua Bratsch-Prince; Sicheng Tang; Burjor Captain; David D Mott; Françisco M Raymo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-01       Impact factor: 11.205

2.  Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk.

Authors:  M Hümpel; I Stoppelli; S Milia; E Rainer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  The effects of lormetazepam on aspects of sleep and early morning performance.

Authors:  Z Subhan; I Hindmarch
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Insomnia in general practice : a consensus report produced by sleep specialists and primary-care physicians in Italy.

Authors:  Mario Giovanni Terzano; Liborio Parrino; Enrica Bonanni; Fabio Cirignotta; Franco Ferrillo; Gian Luigi Gigli; Mariantonietta Savarese; Luigi Ferini-Strambi
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.